Intellectual Property: The Early Decisions That Shape Your Startup
Event description
What should you patent, what should you keep secret, and what should you clarify before spinning out of academia?
Join Nucleate Netherlands for an afternoon exploring the hidden intellectual property decisions that can shape the future of a biotech startup. Together with selected experts from the field, we will discuss common early patent mistakes, practical lessons, and what founders, investors, patent experts, and technology transfer offices look for when academic science starts moving towards company creation.
The event will include an engaging and light-hearted EP&C talk on early patent mistakes, a curated panel discussion on “The Hidden IP Decisions That Shape a Biotech Startup’s Future,” an audience Q&A, networking drinks, and optional 1:1 sessions with EP&C patent attorneys. The 1:1 sessions are completely free of charge. Places are limited and must be requested when signing up for the event.
Who should join?
This event is for PhD students, postdocs, students, researchers, aspiring life sciences and biotech founders, early-stage startup teams, and other trainees curious about how intellectual property affects the journey from academic discovery to biotech company.
Program*
14:30 — Welcome from Nucleate Netherlands and UtrechtInc
14:45 — EP&C talk: Patent mistakes biotech startups make early
15:15 — Coffee break
15:30 — Panel: The Hidden IP Decisions That Shape a Biotech Startup’s Future (panellists TBA)
16:15 — Audience Q&A
16:30 — Networking drinks and optional 1:1 EP&C clinic sessions
17:30 — End of event
*The program is subject to change.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Fenwick, Excedr, Mercury, Brex, Fedsprout, Browne Consulting
In-Kind Support: AcademicLabs, Lens.org